Australia's Monash IVF is an attractive asset, says Jefferies

Monash IVF

13/01/2026 21:04

** Jefferies views Australia's Monash IVF MVF.AX as an attractive asset, despite consortium withdrawing A$311.7 million ($208.25 million) takeover offer in 2025

** "Would not be surprised to see further potential corporate actions over time" — Jefferies

** Brokerage keeps its forecasts unchanged

** Rates stock "buy", hikes PT to A$0.95 from A$0.80 per share

** Jefferies says supportive demographics and IVF being a high cash flow business have lured in private equity interest in the IVF sector

** Three of six analysts rate the stock "buy" or higher, three "hold"; their median PT is A$0.84 — LSEG data

** Stock lost over 40% in 2025

($1 = 1.4968 Australian dollars)

(Reporting by Rajasik Mukherjee in Bengaluru)

((Rajasik.Mukherjee@thomsonreuters.com))